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Abstract Cyclic diaryl ethers are present in multiple natural com-
pounds, organic pollutants as well as in -conjugated organic 
molecular materials. This short review aims at overviewing the main 
synthetic ad-vances in the O-annulation methods for preparing five-, 
six-, and seven-membered rings through C–H cleavage.  
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1 Introduction 
 
Cyclic diaryl ether motifs are found in a large variety of organic 
molecules, spamming from natural products to polycyclic aromatic 
hydrocarbon (PAHs) structures (Figure 1). The antibiotic drug 
Vancomycin is probably the most fa-mous structure.
1a
 Other 
examples include Vicanicin, a li-chen second  
metabolite depsidone exhibiting antitumor ac-tivity,
1b
 and 
Asterelin A, an antifungal drug (Figure 1, top).
1c 
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Concerning artificial cyclic ethers, the polychlorinated dibenzo-
p-dioxins and polychlorinated dibenzofurans are certainly the 
most infamous examples, being in the ‘Dirty Dozen’ list of 
Persistent Organic Pollutants (POPs) (Figure 1, centre).
2
 
Cyclic ethers also constitute the core of O-doped  
 
 
polycyclic aromatic hydrocarbons (PAHs), a class of elec-tron-rich 
aromatics used to engineer organic semiconduc-tors (Figure 1, 
bottom). For instance, derivatives of Pum-merer’s peri-
xanthenoxanthene (PXX) have been used as organic 
semiconductors for engineering the first Sony’s ‘Rollable OTFT-
driven OLED that can wrap around a Pencil’.
3
 2H-Pyran- 
 
based dithienopyran (DTP)
4
 and dibenzopyran (DBP)
5
 motifs 
were introduced as the electron-donating moiety in donor-
acceptor (D–A) type conjugated copoly-mers to engineer solar 
cells with high power conversion ef-ficiencies (PCEs). 
Molecular units based on 9-[3-(diben-zo[b,d]furanyl)phenyl]-
9H-carbazole (DFPCz) scaffold have been used as organic 
phosphors in PHOLEDs.
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Figure 1 Examples of natural and artificial products featuring 
cyclic ether structural motifs 
 
Very interesting p-type organic semiconductor based on O-
doped quinoidal pentacenes and nonacenes were recent-ly 
prepared following a cross-condensation route.
7
 At the 
synthetic planning level, cyclic diaryl ethers are usually pre-
pared through an intramolecular coupling reaction be-tween a 
phenol moiety and a pre-functionalized aryl sub-strate. In 
particular, two routes have been mostly exploited:  
 
 
(i) transition-metal-catalysed C–O cross-coupling reactions 
(i.e., Buchwald–Hartwig,
8
 Ullmann etherification,
9
 and 
Chan–Lam–Evans
10
 coupling), and (ii) nucleophilic 
aromatic substitution reactions.
11,12
 Both synthetic 
approaches rely on the use of electrophilic aromatic halides 
or strong acidic conditions to ensure the ‘activation’ of the 
aryl substrate and control the regioselectivity of the addition 
reaction (Scheme 1).  
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Scheme 1 General methodologies for preparing diaryl ethers 
 
Also, the electrophilic partner needs to be pre-function-
alised at a given position with electron-withdrawing groups 
(EWGs)  and  undergoes  metal-arene  formation,
13
  di-aryl  
iodonium salt,
14
 and in situ formation of benzyne spe-
cies
15
 to favour the relevant addition reaction (Scheme 1). 
Cross-condensation reaction promoted by strong acids is 
also a valuable route when the substrate is not acid-sensi-
tive.
16
 The interested reader can refer to recent reviews 
tackling these synthetic routes.
17
 A more attractive route 
would involve the formation of a cyclic diaryl ether through 
direct C–H functionalisation of an aryl substrate with a giv-  
 
 
 
en phenolic moiety. It is with this aim that in this review 
paper we describe the recent synthetic developments tack-
ling the formation of cyclic diaryl ethers using an intramo-
lecular etherification route involving a C–H cleavage reac-
tion. This review will provide an exhaustive picture of the 
synthetic plans involving the specific reactions and sub-
strates to give five-, six-, and seven-membered rings. 
 
2 Five-Membered Rings: The 
Dibenzofuran (DBF) Motif 
 
2.1 Palladium-Catalysed C–H Activation 
 
In 2011, Liu and co-workers
18
 described the first transi-
tion-metal-catalysed cyclisation reaction involving a C–H 
activation/C–O bond formation to obtain dibenzofuran de-
rivatives by aerobic oxidation starting from 2-phenylphenol 1. 
Their method involves the use of Pd(OAc)2, 1,3-bis(2,6-di-
isopropylphenyl)imidazole-2-ylidene (IPr), mesitylene car-
boxylate (MesCOONa), 4,5-diazafluoren-9-one as ancillary 
ligands, and K2CO3 (Scheme 2). The use of the anionic ligand 
MesCOONa serves as a proton shuttle to promote C–H acti-
vation and 4,5-diazafluoren-9-one to favour the aerobic ox-
idation of the Pd(0)-based species to active Pd(II) complex-es. 
Substrates bearing electron-donating groups (EDGs: amine, 
ether, ketal, and silyl) as well as electron-withdraw-ing groups 
(EWGs: cyano, ketone, nitro, amide, ester, sul-fonamide, 
fluoride, chloride, and trifluoromethyl) on both the aryl and 
phenol moieties were used. Kinetic isotope ef-fect (KIE) 
investigations suggested that the rate determining step is the 
C–O reductive elimination. Moreover, the reac-tion occurs 
quantitatively and regioselectivity at the least sterically 
hindered C–H positions.  
 
Pd(OAc)2 (5 mol%)  
IPr (10 mol%)  
MesCOONa (2 equiv) 
OH 4,5-diazafluoren-9-one 
O 
K2CO3 (2 equiv) 
 
 
 
for the regeneration of the active palladium species. Mix-ture of 
aromatic and Lewis-basic solvents, such as C6F6 and DMI 
(1,3-dimethyl-2-imidazolidinone) (3:2 ratio), gave the highest 
yield. With respect to Liu’s Pd-catalysed cycloether-ification 
reaction, in this case, KIE investigations suggests that the rate 
determining step is the C–H bond cleavage (kH/kD = 1.9). 
Building on these kinetic studies, and consid-ering that 
BzOOtBu is a stronger oxidant than O2, the au-thors suggested 
that the reaction is initiated by a C–H bond cleavage through 
the formation of pallada(II)cycle interme-diate 3. The latter is 
subsequently oxidised by BzOOtBu to give pallada(IV)cycle 4. 
The latter intermediate can reduc-tively eliminate a Pd(II) 
specie, forming the C–O bond, and yielding dibenzofuran 2. As 
described for the reaction above, also in this case the C–O 
bond formation occurs at the least sterically hindered position. 
Notably, substrates bearing either EWGs or EDGs tolerate the 
oxidative reaction conditions. Building on this work, Schmidt 
and Riemer
20
 re-cently described a microwave-promoted 
cyclisation proto-col, in which oxidative C–H activation using 
catalytic amounts of Pd(OAc)2 could be used to prepare DBFs. 
The re-action works under water-free conditions in non-protic 
sol-vents such as benzene and ethereal solvents (THF, MTBE, 
DME, or DDME).  
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Scheme 3 Pd-catalysed DBF formation reported by Wei and Yoshikai
19 
 
Scheme 2 Palladium-catalysed DBF formation reported by Liu 
and co-workers
18 
 
In parallel, Wei and Yoshikai
19
 developed a base-free 
method using Pd(OAc)2 and 3-nitropyridine as the ligand 
(Scheme 3). Under these conditions, aerobic oxidation is in-
efficient and BzOOtBu was used as an inexpensive oxidant  
 
In 1980, Kappe and co-workers presented a non-CH ac-
tivated Pd-catalysed diaryl ether formation relying on cy-
clodehydrogenation of 4-hydroxy-3-phenylquinolinone 5, 
quinolinylphenol 7, and hydroxyphenylphenalenone 9 to 
prepare the corresponding furan derivatives 6, 8, and 10  
(Scheme 4).
21
 This method was further used to synthesise 
biologically active benzofuroquinolinone.
22 
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Scheme 4 Palladium-catalysed cyclodehydrogenation for the forma-tion 
of benzofuranes as developed by Kappe and co-workers
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2.2 Copper-Mediated C–H Activation 
 
In 2012, Zhu and co-workers published three papers on the 
dibenzofuran synthesis through C–H bond cleavage/C– O  
bond formation using Cu-based catalysts.
23–25
 The use of 
copper is more convenient compared to other transition metals 
as it is considerably cheaper and compatible with O2. However, 
the presence of relatively strong EWGs on the phenolic ring 
(e.g., nitro, cyano, and carbonyl groups) is re-quired to 
overcome undesired homocoupling of phenols or other side-
reactions usually promoted by copper. In the first protocol, 
CuBr was used (30%) in the presence of Cs2-CO3, and pivalic 
acid in the air (Scheme 5).
23
 Notably, ortho-functionalised 
substrates did not allow formation of the C– O bond, whereas 
the meta congeners gave the cyclised products with a 20:1 
regioselective ratio toward the least sterically hindered isomer. 
For substrates bearing bulky substituents such as I or Ph, 
Cu(OAc)2 was used to avoid the formation of undesired 
brominated by-products. As men-tioned above, the phenolic 
ring can only bear EWGs, where-as the phenyl ring tolerates 
both EWGs and EDGs.  
Together with a KIE value of 4.5, the absence of proton 
scrambling suggested that the C–H bond cleavage is the rate 
determining step. As studies with competitive reactions be-
tween electron-rich and -poor aryl substrates did not give any 
conclusive results, the authors suggested that the cycli-sation 
reaction could result from either a concerted metala-tion 
deprotonation (CMD) mechanism or an electrophilic 
substitution (Scheme 5, paths a,b, respectively). A radical 
pathway was excluded as the reaction is not affected by the 
presence of a radical scavenger such as TEMPO. As there are 
no evidences for the Cu(II)/Cu(0) couple involvement, the 
oxidative Cu(III)/Cu(I) cycle could not be completely exclud-ed. 
In a subsequent work,
24
 the same authors reported on the 
development of an efficient Cu-catalysed oxidative C–O bond 
formation of electron-deficient ortho-phenols con-taining 
supplementary directing meta-groups (e.g., NHAc , NHCOPh, 
2-pyrrolidone, and NHBoc) on the non-phenolic  
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Scheme 5 Cu-catalysed DBF formation reported by Zhu and co-  
work-ers.
23
 Proposed mechanistic pathways: (path a) concerted 
metalation deprotonation and (path b) electrophilic metalation. 
 
ring. Together with the hydroxy group, the amidic carbonyl 
functional group chelates the copper metal centre allowing the 
reaction to be performed without a base and at low 
temperatures. Notably, high yields (up to 99 %) and a broad 
substrate scope with full control on the regioselectivity could be 
achieved with these substrates (Scheme 6). In a later work, 
Zhu and co-workers reported the first example of a sequential 
iodination-cycloetherification reaction of o-arylphenols 
mediated by CuI in the presence of O2. 
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Scheme 6 Cu-catalysed DBF formation reported by Zhu and co-
work-ers
24 
 
This permitted the synthesis of 2- and 4-iododibenzofu-
rans derivatives using CuI as both iodinating agent and cat-
alyst for the C–H activation/C–O bond formation. Iodination of 
the phenolic ring at either the ortho or para positions de-
pending on the position of the EWG was observed (Scheme 
7).
25
 Notably, a thermal control of the iodination reaction to 
occur prior to the C–O cyclisation could be obtained. Heat-ing 
the reaction mixture at 60 °C gave first the iodo-inter-  
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mediate that, at 140 °C, could be cyclised into the furanyl 
derivatives in the presence of a stoichiometric amount of 
CuI (Scheme 8). 
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Scheme 8 Sequential Cu-catalysed iodination and C–O cyclisation 
re-ported by Zhu and co-workers.
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This reaction tolerates EWGs (e.g., Cl, F, CF3, NO2, CN, 
and CHO) and EDGs (e.g., Me, OMe, and Ph). Notably, re-
placing the CuBr with CuI, the corresponding brominated 
product could be obtained. As in all cases discussed above, 
the reaction occurs at the least hindered position (regiose-
lectivity 5:1). Capitalising on KIE experiments (4.1) and 
mechanistic studies using DFT calculations, the authors 
suggested that the reaction occurs through a pivalate-as-sisted 
CMD pathway (Scheme 8) initiated by Cu(III) species. Single 
electron transfer (SET) or electrophilic aromatic sub-stitution 
(SEAr) mechanisms were excluded. 
 
2.3 Non-CH Activation Oxidant-Mediated 
Cyclisa-tion 
 
Other convenient synthetic methods to form furan cy-
cles include oxidation methods that do not involve any di-
rect C–H activation, such as (i) transition-metal-free oxida- 
zoquinone 33. Subsequent intramolecular 1,4-addition of the 
neighbouring hydroxyl groups, followed by a tautomer-
isation/rearomatisation reactions, gave dibenzofuranes 34 and 
32, respectively (Scheme 11). Commonly used oxidants for 
this transformation are Ag2O,
28
 MnO2, 
29
, and 
K3[Fe(CN)6].
30
 Capitalising on this reaction, Lu and co-work-
ers prepared derivative 35, an important intermediate for the 
total synthesis of (±)-anastatins A and B (Scheme 11).
31 
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Scheme 9 Synthesis of asterelin A by Makino et al. involving an 
oxida-tive cyclisation
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  (Scheme 9), (ii) 
intramolecular cyclisation of 2,2′-biphenoquinone
27
 
(Scheme 10), and (iii) oxidation/oxa-Michael cascade reac-
tion (Scheme 11). The latter method relies on the oxidation 
of a pyrocatechol moiety 31 to the corresponding 1,2-ben-  
33 
34 
 
[Ox] = Ag2O, MnO2, K3[Fe(CN)6] 
 
Scheme 11 General oxidative formation of DBF through quinone 
for-mation (left) as reported by Lu and co-workers
31 
 
 
 
2.4 Light-Mediated Cyclisation 
 
The formation of dibenzofurans was also obtained by 
photoirradiation of phenols precursors through Excited 
State Intramolecular Proton Transfer (ESIPT). For example,  
Wan and co-workers
32
 observed the formation of diaryl fu-
rans in low yield (2–9%) when 1-(2,5,dihydroxyphe-
nyl)naphthalene (36) was exposed under irradiation at 300 
nm. Notably, different products were obtained depending 
on the solvent polarity. For instance, in aprotic solvents, a 
predominant C–C bond migration was observed yielding 2-
(2,5-dihydroxyphenyl)naphthalene (38) and naphthoben-
zofuran-8-ol (37) as the major (60% yield) and minor (9% 
yield) products, respectively. In protic solvents, an intramo-
lecular proton transfer followed by electrocyclic ring clo-
sure was instead observed, with dihydrobenzoxanthene 40 
(53% yield) being the only product (Scheme 12). Molecule 
40 can undergo further oxidation to give the pyran deriva- 
 
tive.  
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Scheme 12 Light-induced oxidative formation of DBF motifs
32 
2.5  Acid-Catalysed C–O Cleavage/C–O Formation 
Biphenol 41  can  be transformed  into dibenzofuran  2a  
through C–O cleavage/C–O formation, likely following a SEAr 
mechanism (Scheme 13). This reaction is usually car-ried out 
in the presence of either strong Brønsted acids
33–35
 (e.g., 
PTSA, TfOH, H2SO4, and HBr), Lewis acids
36
 (e.g., SnCl4, 
Al2O3, and zeolite) or noble metal surfaces [e.g., Au(111) and 
Ag(111)].
37
 The latter method has been largely reported in the 
literature for the preparation of organic materials such as O-
doped graphenes
37
 and helicenes.
38 
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Scheme 13 Formation of DBF from 2,2′-biphenol  
 
 
3 Six-Membered Rings: DBX, PXX, 
Xanthone, and Their Derivatives 
  
Concerning the six-membered cyclic ethers, these can 
be classified as: (i) dibenzoxanthene (DBX), (ii) peri-
xanthe-noxanthene (PXX), (iii) xanthones (presenting a 
carbonyl group joining both aromatic cycles), (iv) 
miscellaneous de-rivatives featuring both five- and six-
membered rings, and (v) phenoxazines. 
 
3.1 Dibenzoxanthene (DBX) 
 
The first synthetic protocol for the preparation of diben-
zoxanthenes (DBX) 43 from a tetra-tert-butylated BINOL  
derivative was developed in 1963 by Rieche et al.,
39
 and lat-er 
optimised by Schneider et al.
40
 Their methods use 
K3[Fe(CN)6] yielding DBXs in 38%. In 2001, Xu et al. discov-
ered the almost quantitative formation of DBX using Cu(II)-
amine complexes in hot MeOH in the presence of air.
41
 This 
method tolerates a large variety of amines with the highest 
reaction rate observed when using ethanolamine. More-over, 
modification of the alcoholic solvent leads to a variety of 
derivatives bearing different alkyl ether functionality (Scheme 
14). Racemic mixture was obtained when a chiral amine was 
used or optically pure BINOL was selected as starting material. 
Based on this observation, they proposed a mechanistic 
pathway involving the oxidation of BINOL 42 to naphthoxy 
radical 44, which is in equilibrium with its carbon-centred 
radical analogue 45. The latter radical can be trapped by the 
alcoholic solvent forming -alkyloxy ke-tone 46, which could be 
further oxidised to form DBX 43 (Scheme 14). Later, this 
synthetic method was used for the  
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Scheme 14 Oxidative formation of DBX from BINOL
41 
 
 
 
synthesis of cancer drugs
42
 or isolated as side product 
during the deracemisation of BANOL, a phenanthrene de-
rivative of BINOL.
43 
 
3.2 Peri-Xanthenoxanthene (PXX) 
 
The first synthesis of PXX dates back to the beginning 
of the 20th century when Bünzly and Decker
44
 described 
the oxidation of BINOL in the presence of K3[Fe(CN)6]. 
Shortly after, Pummerer used Ag2O, CuO, and Cu(OAc)2 
for the same transformation.
45
 In 2001, Tamotsu and co-  
workers
46
 revis-ited Pummerer’s protocol, with Cu(OAc)2 in 
aqueous alka-line solution (Table 1).  
In 2007, Weinert and co-workers studied the oxidation of 
3,3′-disubstituted BINOL in the presence of a sterically  
encumbered mercury salt, (Hg[N(SiMe3)]2) (50).
47
 Depend-ing 
on the equivalent of oxidant involved in the reaction, they were 
able to isolate monopyranyl pentacyclic 54. Based on 
1
H and 
199
Hg NMR, they have proposed a mecha-nistic pathway 
involving a mercuration reaction of the hy-droxyl groups 
followed by intramolecular electrophilic aro-matic substitution 
and extrusion of elemental Hg (Scheme 15). Following these 
reports, Cui and co-workers recently developed an 
improvement of the synthesis of PXX using Cu(OAc)2 in ortho-
dichlorobenzene at 190 °C under micro-wave irradiation for 
only 3 minutes.
48
 In 2016, our group re-ported the synthesis of 
PXX and PXX-analogues
49
 by adapt-ing Zhu’s protocol for 
dibenzofuran. Specifically, CuI and pivalic acid in DMSO at 140 
°C were used. Song and Swager also reported on the 
electrochemical cyclisation of BINOL derivatives to yield PXX-
thiophene-based conducting poly-  
Table 1 Oxidative Formation of PXX from BINOL 
 
 
 
mers.
50
 The last to date synthetic protocol for the cyclisa-
tion of BINOL to PXX relies on the use of CuCl with N-me-
thylimidazole and K2CO3 as a base in hot m-xylene.
51
 This 
method allows not only the formation of PXX at lower tem-
perature, but to perform cascade dimerisation/cyclisation of 
simple naphthols. Similarly, Fuchs and co-workers used on-
surface protocols to produce DBF- and/or PXX-polymers 
from 6,6′-dibromo-BINOL derivatives.
37 
  
   R  
R  R   
  
Hg[N(SiMe3)2] 
O 
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OH 50 O H   HgN TMS 
HO – HN(SiMe3)2 HO HO  
    
   +  
R  R R  
49  51 52   
50: Hg[N(SiMe3)2]2  
 
R = H, SiMe3, SiMe2Ph, SiMePh2 or SiPh3 
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55  54  53 
 
Scheme 15 Proposed formation mechanism for PXX by 
Weinert and co-workers
47 
 
Building on the Cu-based protocols, our group could 
achieve the synthesis of extended PXX derivatives. In par-  
ticular, O-doped armchair 56, 57
49
 and zig-zag 58 
52
 molecu-
lar ribbons, coloured -extended PXX 59 and 60,
35
 and 
monoimide(PXXMI)/diimide(PXXDI) derivatives 61 and 62 
 
    
R 
      
[Ox] 
 
R 
          
                     
        OH        O    
                   
     
HO 
     
O 
      
                
          
R 
        
R 
   
                     
                        
    47    48       
                       
  Reaction conditions:                     
  Year Reagents R   Solvent   Temp/Time Yield  
              
1905
44 
[K3Fe(CN)6] H   –   –  –  
1914
45 
Ag2O H   benzene   80 °C/1 h –  
1914
45 
Cu(OAc)2/CuO H   PhNO2 280 °C/3 h 52–80  
2001
46 
Cu(OAc)2 H   aq NaOH   r.t./1 h –  
2007
47 
Hg[N(SiMe3)]2 H, silyl   benzene   85 °C/24 h 49–97  
2013
48 
Cu(OAc)2, O2 n-octyl   ODCB, pyridine 190 °C MWI/3 min 44–56  
2016
49 
CuI, PivOH, O2 2,4-di-tBuPh   DMSO 140 °C/2 h 94  
2009
50 
NOBF4 thiophene   CH2Cl2   r.t./6 h 42–78  
2017
51 
CuCl, NMI, K2CO3, air H, TMS, alkyl, aryl, CO2Me, allyl m-xylene 120 °C/20 h 55–99  
                       
 
 
 
 
were synthesised by our group (Figure 2).
53
 In-depth photo-
physical and electrochemical studies revealed that all pyra-
nopyran derivatives feature strong electron-donating prop-
erties due to their high-lying energy HOMO levels.
52,53
 In 
particular, PXX, PXXMI, and PXXDI revealed to be strong 
photoreducers, with PXX featuring the same photoreducing 
potential as that of the commonly used Ir(III) complexes.
53a 
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Figure 2 Chemical structures of extended PXX-based molecular 
archi-tectures 
 
3.3 Xanthones 
 
Being xanthones (i.e., 9H-xanthen-9-ones) important 
building blocks constituting various pharmacological activ-ities, 
they have been at the centre of a lot interest in syn-thetic  
organic chemistry.
54
 For example, Norathyriol is a 
chemopreventive agent that is effective against skin can-cer.
55
 
Daviditin A is used to relax the corpus cavernous smooth 
muscle, while its Bellidifolin congener is a potent hypoglycemic 
regulator, improving insulin resistance.
56
 Fi-nally, Atroviridin 
exhibits anti-inflammatory activity and is traditionally used for 
the treatment of earache (Figure 3).
57
 In this regard, research 
groups have focused on the synthet-ic methodologies that use 
biogenetic-type approaches to perform the oxidation of the 
benzophenone core 63. Poly-hydroxylated and methoxylated 
derivatives were common-ly used as substrates and treated 
with various oxidants such as K3Fe(CN)6,
58–61
 CrO3,
59
 p-
chloranil,
59
 KMnO4,
59,60
 K2S2O8,
60
 Mn(OAc)3,
61
 
Pb(OAc)4,
61
 and silver salts
62
 (Scheme 16).  
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Scheme 16 Formation of xanthone by oxidation of 
polyhydroxylated benzophenone 
 
In some case, enzymatic oxidation,
60
 using Horse Radish 
Peroxidase Laccase or even microorganism as R. Buffonii,
55
 
has been used as well. In the case of silver salts,
62
 Fuse et al. 
suggested a radical mechanism for the formation of 1,7-di-
hydroxyxanthone 69. In the proposition, a single electron 
transfer (SET) to form xanthone ring 67 occurs, generating a 
radical intermediate stabilised by the 3-hydroxyl group. This is 
followed by a second SET, resulting in the re-aroma-tisation 
reaction forming xanthone core 69 (Scheme 17).  
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Scheme 17 Proposed radical mechanism for the formation of 
1,7-di-hydroxyxanthone
62 
 
Recently, Suzuki et al.
63
 developed the total synthesis 
of Atroviridin using MnO2 as oxidant to form the xanthone 
core. In their case, the proposed mechanism relies on the 
formation of p-quinone 71 followed by a 1,4-addition of the 
free hydroxyl group leading to keto-tautomer intermediates 
72 and 73, which are demethylated to yield Atroviridin 
(Scheme 18).  
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Scheme 18 Proposed mechanism for the formation of Atroviridin
63 
 
3.4 Miscellaneous 
 
3.4.1 Conjugated Addition on Quinone 
 
In 2006, Yoshida reported a synthesis of furanyl and 
pyranyl derivatives based on the conjugated Cu- and Ni-
promoted addition of a hydroxyl group on the adjacent or-
tho-quinone moiety (Scheme 19).
64 
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Scheme 19 Synthesis of furan and pyran derivatives 
through quinone intermediates
64 
 
During the study of the reaction, they observed that 
Cu(OAc)2 was the most effective oxidiser, and that the sol-vent 
polarity has a strong effect on the regioselective out-come of 
the cyclisation. For instance, in the case of DMSO, six-
membered ring was preferentially obtained (ratio of 4.4:1), 
whereas in MeNO2 only the five-membered ring was formed. 
Another method for preparing cyclic diaryl ethers is based on 
Flash Vacuum Pyrolysis (FVP). The idea of this approach is to 
generate hydroxyl radical species that under-go an 
intramolecular cyclisation reaction. However, these 
 
 
 
 
reactions are usually low yielding and lack regioselectivity. 
In their early report, Cardogan and McNab described the 
cy-clisation of 2-(allyloxy) or 2-(benzyloxy)diphenylmethane 
81 to produce xanthene 82, fluorene 83, and phenol 84 de-
rivative. In the case of 2-(allyloxy)benzophenone 85, they 
were able to obtain a mixture of xanthone 86, fluorenone 
87, methylbenzylphenol 88, and dibenzofuran 89 (Scheme 
  
20).
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Scheme 20 C–O bond formation by Flash Vacuum Pyrolysis
65 
 
3.4.2 Phenoxazine 
 
Phenoxazines (POZs) are natural organic dyes that can be 
used in applications such as hole-transporting materials, bio-  
imaging, dye-sensitised solar cells (DSSCs), and lasers.
66
 POZs 92 is 
usually obtained by oxidative cyclisation of 2-(phenylamino)phenol 91 
in the presence MnCl2
67
 PbO2 
68
 or 
 
Substrates  bearing  EWGs  (e.g.,  nitro,  cyano,  and 
 
acetyl groups) revealed to be compatible with the oxidative 
reaction conditions (Scheme 21).  
 
 EWG  EWG 
H    H 
N  [Ox] N 
      
OH    O 
91    92  
 [Ox] = MnCl2, PbO2, CoCl2   
 EWG = NO2, CN, CHO   
 
Scheme 21 Phenoxazine formation 
 
4 Seven-Membered Rings: Cularines 
 
The most common C–H bond cleavage/C–O bond forma-
tion developed so far for engineering O-annulated seven-
membered rings is that used for the synthesis of cularines. In 
1974, Jackson et al. reported an oxidative intramolecular 
coupling of tetrahydrobenzylisoquinoline derivatives 93a in the 
presence of K3[Fe(CN)6] to produce cularine 94a and 
 
isocularine 95a in 2.5%, and 5% yield, respectively.
70
 The 
CoCl2.
69 
 
 
method was improved by using an N-borane complex of 
93b, treating it with VOF3 to yield 94b in 56% yield 
(Scheme 22).
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Scheme 22 Synthesis of cularines and isocularines with 
K3[Fe(CN)6]
70
 and VOF3
71 
 
Instead, the synthesis of didehydronorcularine 97 was 
achieved by Rodrigues and Abramovitch using 
C6F5I(OCOCF3)2, yielding the desired cyclic diaryl ether in 
87%, together with traces of ortho-cyclised derivative 98 
(Scheme 23).
72
 The same team also reported the 
synthesis of cularines through the use of nitrenium ions 
(Scheme 24), generated in situ by acid-catalysed 
decomposition of the azide precursor 99. 1,4-Type 
intramolecular addition of the peri-hydroxyl group, followed 
by tautomerisation of the imine intermediate, yielded 
amino-didehydronorcularine 102 (81%) as the major 
product.
72
 Notably, the intramolecu-lar addition reaction 
occurs at the least sterically hindered site, namely in para-
position with respect to the amino functionality.  
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5 Conclusion  
 
In conclusion, in this review we have described the cur-rent 
synthetic approaches to prepare cyclic diaryl ethers through C–H 
bond cleavage/C–O bond formation. Our at-tention were focused 
on five- (furano), six- (pyrano), and seven-membered rings. In the 
case of the formation of fura-no-type rings, it is apparent that the 
C–O bond formation mediated by Pd and Cu salts is generally 
triggered by the activation of the C–H bond. High yields are usually 
obtained with metal-catalysed protocols if compared to classical 
oxi-dative or light-driven approaches. As far as the pyrano rings 
are concerned, no clear mechanisms have been postulated so far, 
and the reaction protocol greatly varies depending on the type of 
the six-membered diaryl ether, namely, dibenzoxanthene (DBX), 
peri-xanthenoxanthene (PXX), xanthones, and phenoxazine 
(POZ). At last, seven-mem-bered diaryl ethers are rare, and only 
methods to prepare cularines have been discussed. 
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